Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Sep 2023. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5258424017 | Nicotine (as nicotine polacrilex) 1.5 mg oromucosal lozenge | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5258425016 | Product containing precisely nicotine (as nicotine polacrilex) 1.5 milligram/1 each conventional release oromucosal lozenge (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Nicotine (as nicotine polacrilex) 1.5 mg oromucosal lozenge | Is a | Product containing only nicotine in oromucosal dose form (medicinal product form) | true | Inferred relationship | Some | ||
Nicotine (as nicotine polacrilex) 1.5 mg oromucosal lozenge | Has manufactured dose form | Oromucosal lozenge | true | Inferred relationship | Some | ||
Nicotine (as nicotine polacrilex) 1.5 mg oromucosal lozenge | Has unit of presentation | Lozenge | true | Inferred relationship | Some | ||
Nicotine (as nicotine polacrilex) 1.5 mg oromucosal lozenge | Has precise active ingredient | Nicotine polacrilex | true | Inferred relationship | Some | 1 | |
Nicotine (as nicotine polacrilex) 1.5 mg oromucosal lozenge | Has basis of strength substance (attribute) | Nicotine | true | Inferred relationship | Some | 1 | |
Nicotine (as nicotine polacrilex) 1.5 mg oromucosal lozenge | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Nicotine (as nicotine polacrilex) 1.5 mg oromucosal lozenge | Has presentation strength denominator unit (attribute) | Lozenge | true | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets